CareDx, Inc. corporate insiders have only been selling lately: seven insiders sold about $13.3 million of stock over 12 months, with no open-market purchases.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
Quarter by quarter: 7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. On the institutional side, 227 funds reported holding CDNA at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Bickerstaff George | Director | Sell | 20,000 | $46.29 | $926K | SEC |
| Aug 6, 2026 | COURNOYER CHRISTINE | Director | Sell | 16,000 | $46.94 | $751K | SEC |
| Aug 6, 2026 | Novack Jeffrey Adam | Executive Officer | Sell | 2,188 | $46.15 | $101K | SEC |
| Aug 6, 2026 | Novack Jeffrey Adam | Executive Officer | Sell | 500 | $46.75 | $23K | SEC |
| Aug 6, 2026 | Goldberg Michael | Director | Sell | 44,700 | $47.06 | $2.1M | SEC |
| Jul 17, 2026 | Hanna John Walter JR | CEO | Sell | 68,000 | $39.01 | $2.7M | SEC |
| Jul 17, 2026 | Hanna John Walter JR | CEO | Sell | 50,000 | $36.11 | $1.8M | SEC |
| Jul 17, 2026 | Valantine Hannah | Director | Sell | 100 | $36.55 | $4K | SEC |
| Jul 17, 2026 | Valantine Hannah | Director | Sell | 28,679 | $36.14 | $1.0M | SEC |
| Jun 30, 2026 | Hanna John Walter JR | CEO | Sell | 39,900 | $29.24 | $1.2M | SEC |
| Jun 30, 2026 | Hanna John Walter JR | CEO | Sell | 100 | $29.00 | $3K | SEC |
| Jun 17, 2026 | Hanna John Walter JR | CEO | Sell | 17,683 | $24.03 | $425K | SEC |
| Jun 16, 2026 | Valantine Hannah | Director | Sell | 12,103 | $23.11 | $280K | SEC |
| Jun 15, 2026 | Hanna John Walter JR | CEO | Sell | 21,998 | $24.02 | $528K | SEC |
| Jun 8, 2026 | Hanna John Walter JR | CEO | Sell | 4,835 | $24.00 | $116K | SEC |
In the last 12 months CareDx, Inc. insiders made open-market purchases worth about $0 and sales worth about $13.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CDNA was filed on 2026-08-06.
227 investment managers reported holding CDNA in SEC Form 13F filings for Q2 2026.
No congressional trades in CDNA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).